Witnessing the stock’s movement on the chart, on Wednesday, LENZ Therapeutics Inc (NASDAQ: LENZ) had a quiet start as it plunged -23.46% to $21.47, before settling in for the price of $28.05 at the close. Taking a more long-term approach, LENZ posted a 52-week range of $16.53-$50.40.
The Healthcare sector firm’s twelve-monthly sales growth has been -181.63% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -181.63%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -10.91%. This publicly-traded company’s shares outstanding now amounts to $28.50 million, simultaneously with a float of $24.40 million. The organization now has a market capitalization sitting at $612.37 million. At the time of writing, stock’s 50-day Moving Average stood at $38.98, while the 200-day Moving Average is $30.93.
LENZ Therapeutics Inc (LENZ) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. LENZ Therapeutics Inc’s current insider ownership accounts for 14.45%, in contrast to 93.20% institutional ownership. According to the most recent insider trade that took place on Sep 30 ’25, this organization’s 10% Owner sold 132,944 shares at the rate of 46.01, making the entire transaction reach 6,117,323 in total value, affecting insider ownership by 1,050,599. Preceding that transaction, on Sep 30 ’25, Company’s 10% Owner sold 92,030 for 46.01, making the whole transaction’s value amount to 4,234,695. This particular insider is now the holder of 764,127 in total.
LENZ Therapeutics Inc (LENZ) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
LENZ Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -10.91% and is forecasted to reach -2.69 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 46.00% through the next 5 years, which can be compared against the -181.63% growth it accomplished over the previous five years trading on the market.
LENZ Therapeutics Inc (NASDAQ: LENZ) Trading Performance Indicators
Let’s observe the current performance indicators for LENZ Therapeutics Inc (LENZ). It’s Quick Ratio in the last reported quarter now stands at 20.54. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 122.47.
In the same vein, LENZ’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.90, a figure that is expected to reach -0.89 in the next quarter, and analysts are predicting that it will be -2.69 at the market close of one year from today.
Technical Analysis of LENZ Therapeutics Inc (LENZ)
Going through the that latest performance of [LENZ Therapeutics Inc, LENZ]. Its last 5-days volume of 1.66 million indicated improvement to the volume of 0.44 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 11.45% While, its Average True Range was 11.01.
Raw Stochastic average of LENZ Therapeutics Inc (LENZ) in the period of the previous 100 days is set at 0.89%, which indicates a major fall in contrast to 1.39% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.49 that was higher than 2.35 volatility it exhibited in the past 100-days period.
